C9ORF72

Chr 9AD

C9orf72-SMCR8 complex subunit

Also known as: ALSFTD, DENND9, DENNL72, FTDALS, FTDALS1

The protein encoded by this gene plays an important role in the regulation of endosomal trafficking, and has been shown to interact with Rab proteins that are involved in autophagy and endocytic transport. Expansion of a GGGGCC repeat from 2-22 copies to 700-1600 copies in the intronic sequence between alternate 5' exons in transcripts from this gene is associated with 9p-linked ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia) (PMID: 21944778, 21944779). Studies suggest that hexanucleotide expansions could result in the selective stabilization of repeat-containing pre-mRNA, and the accumulation of insoluble dipeptide repeat protein aggregates that could be pathogenic in FTD-ALS patients (PMID: 23393093). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2016]

Primary Disease Associations & Inheritance

Frontotemporal dementia and/or amyotrophic lateral sclerosis 1MIM #105550
AD
0
ClinVar variants
0
Pathogenic / LP
0.00
pLI score
12
Active trials
Clinical SummaryC9ORF72
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
💊
Clinical Trials
12 active or recruiting trials — potential therapeutic options may be available
Some data sources returned errors (1)

clinvarCount: Error: NCBI fetch failed: 429 https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.93LOEUF
pLI 0.000
Z-score 1.82
OE 0.58 (0.380.93)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
0.24Z-score
OE missense 0.96 (0.861.06)
240 obs / 250.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.58 (0.380.93)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.96 (0.861.06)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.16
01.21.6
LoF obs/exp: 13 / 22.3Missense obs/exp: 240 / 250.9Syn Z: -1.20

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

C9ORF72 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Frontotemporal dementia and/or amyotrophic lateral sclerosis 1

MIM #105550

Molecular basis of disorder known

Autosomal dominant
Clinical Literature
Landmark / reviewRecent case evidence

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Frontotemporal DementiaFTDFTD-GRN

A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes

RECRUITING
NCT04747431Phase PHASE1, PHASE2Passage Bio, Inc.Started 2021-09-14
PBFT02
Bipolar DisorderFrontotemporal Dementia, Behavioral Variant

A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated Approach

RECRUITING
NCT06706687Phase NAFondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoStarted 2021-05-19
DISBAND protocol
ALS

Amyotrophic Lateral Sclerosis (ALS) Families Project

RECRUITING
NCT03865420Columbia UniversityStarted 2018-09-11
Amyotrophic Lateral Sclerosis (ALS)

Testing Pulse Stimulation to Improve Motor Function in People With ALS: A Pilot Study

RECRUITING
NCT06681610Phase NAParc de Salut MarStarted 2024-10-24
Transcranial Pulse Stimulation
Neurodegenerative DiseasesDementia

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

RECRUITING
NCT06339190Monash UniversityStarted 2021-08-01
Venepuncture
ALS (Amyotrophic Lateral Sclerosis)

Amyotrophic Lateral Sclerosis Registry in Thailand

RECRUITING
NCT07175935Chulalongkorn UniversityStarted 2025-03-01
Frontotemporal DementiaFrontotemporal Lobar DegenerationFTD-GRN

Neurofilament Surveillance Project (NSP)

ACTIVE NOT RECRUITING
NCT04516499The Bluefield Project to Cure Frontotemporal DementiaStarted 2020-09-02
Amyotrophic Lateral Sclerosis

Needs of ALS Patients With C9orf72 Mutation and Their Caregivers

RECRUITING
NCT07302321Istituto Auxologico ItalianoStarted 2025-10-01
Survey for ALS patientsSurvey for Caregivers
Amyotrophic Lateral SclerosisFrontotemporal DementiaALS-Frontotemporal Dementia

TRIAL READY (Clinical Trial Readiness)

ACTIVE NOT RECRUITING
NCT03912987University of MiamiStarted 2019-01-22
C9orf72 Amyotrophic Lateral Sclerosis (ALS)Frontotemporal Dementia

Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD

ACTIVE NOT RECRUITING
NCT04220021Phase PHASE2University of FloridaStarted 2020-01-10
Metformin
Frontotemporal Dementia

GENetic Fronto Temporal Dementia Initiative in Lille

RECRUITING
NCT04639622Phase NAUniversity Hospital, LilleStarted 2019-04-23
Investigation procedures
Amyotrophic Lateral Sclerosis

Longitudinal Assessment of Autonomic and Sensory Nervous System in ALS

RECRUITING
NCT05747937Phase NAIstituti Clinici Scientifici Maugeri SpAStarted 2021-05-15
Skin biopsyCardiovascular Reflexes testingAdministration of clinical scales evaluating autonomic symptoms, pain small fiber neuropathy symptoms